Medication for complex posttraumatic disorders

Journal of Aggression, Maltreatment and Trauma

Volumn 20, Issue 6, 2011, Pages 645-668

  Laddis, Andreas ^a  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

catastrophic reflex; medication algorithm; natural remission; realistic expectations; traumatic betrayal

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CITALOPRAM; CLONAZEPAM; DESVENLAFAXINE; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; HYDROXYZINE; IMIPRAMINE; LORAZEPAM; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; MOOD STABILIZER; NEFAZODONE; NEUROLEPTIC AGENT; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

DISEASE COURSE; DRUG EFFICACY; HUMAN; POSTTRAUMATIC STRESS DISORDER; PSYCHOTHERAPY; RECURRENT DISEASE; REVIEW;

EID: 80052501663     PISSN: 10926771     EISSN: 1545083X     Source Type: Journal    
DOI: 10.1080/10926771.2011.596137     Document Type: Review

References (146)

1. Akiskal, H. S. (2007). The emergence of the bipolar spectrum: Validation along clinical-epidemiologic and familial-genetic lines. Psychopharmacology Bulletin, 40(4), 99-115.
2. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text revision). Washington, DC: Author.
3. American Psychiatric Association. (2001). Practice guideline for the treatment of patients with borderline personality disorder. American Journal of Psychiatry, 158(Suppl. 10), 1-52.
4. American Psychiatric Association. (2004). Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. American Journal of Psychiatry, 161(Suppl. 11), 3-31.
5. Bateman, A. W., & Fonagy, P. (2000). Effectiveness of psychotherapeutic treatment of personality disorder. British Journal of Psychiatry, 177, 138-143.
6. Bateman, A. W., & Tyrer, P. (2004). Psychological treatment for personality disorders. Advances in Psychiatric Treatment, 10, 378-388.
7. Bellino, S., Paradiso, E., & Bogetto, F. (2006). Mood stabilizers and novel antipsychotics in the treatment of borderline personality disorder. Psychiatric Times, 23(8). Retrieved from http://www.psychiatrictimes.com/ display/article/10168/ 46801
8. Benjamin, L. S. (1997). Special feature: Personality disorders: Models for treatment and strategies for treatment development. Journal of Personality Disorders, 11(4), 307-324.
9. Bradley, R., Greene, J., Russ, E., Dutra, L., & Westen, D. (2005). A multidimensional meta-analysis of psychotherapy for PTSD. American Journal of Psychiatry, 162(2), 214-227.
10. Brett, E. A. (1996). The classification of posttraumatic stress disorder. In B. A. van der Kolk, A. C. McFarlane, & L. Weisaeth (Eds.), Traumatic stress: The effects of overwhelming experience on mind, body and society (pp. 117-128). New York: Guilford.
11. Byrne, R. M. J. (2005). The rational imagination: How people create alternatives to reality. Cambridge, MA: The MIT Press.
12. Cahill, S. P., Rothbaum, B. O., Resick, P. A., & Follette, V. M. (2009). Cognitivebehavioral therapy for adults. In E. B. Foa, T. M. Keane, M. J. Friedman, & J. A. Cohen (Eds.), Effective treatments for PTSD: Practice guidelines from the International Society for Traumatic Stress Studies (pp. 139-222). New York: Guilford.
13. Classen, C., Pain, C., Field, N. P., & Woods, P. (2006). Posttraumatic personality disorder: A reformulation of complex posttraumatic stress disorder and borderline personality disorder. Psychiatric Clinics of North America, 29(1), 87-112.
14. Davidson, J. (1994). Issues in the diagnosis of posttraumatic stress disorder. In R. S. Pynoos (Ed.), Posttraumatic stress disorder: A clinical review (pp. 1-15). Lutherville, MD: Sidran Press.
15. Duke, L. M., & Vasterling, J. J. (2005). Epidemiological and methodological issues in neuropsychological research on PTSD. In J. J. Vasterling & C. R. Brewin (Eds.), Neuropsychology of PTSD: Biological, cognitive and clinical perspectives (pp. 3-24). New York: Guilford.
16. Foa, E. B., Keane, T. M., Friedman, M. J., & Cohen, J. A. (Eds.). (2009a). Index: Treatment guidelines. In E. B. Foa, T. M. Keane, M. J. Friedman, & J. A. Cohen (Eds.), Effective treatments for PTSD: Practice guidelines from the International Society for Traumatic Stress Studies (pp. 537-613). New York: Guilford.
17. Foa, E. B., Keane, T. M., Friedman, M. J., & Cohen, J. A. (2009b). Introduction. In E. B. Foa, T. M. Keane, M. J. Friedman, & J. A. Cohen (Eds.), Effective treatments for PTSD: Practice guidelines from the International Society for Traumatic Stress Studies (pp. 1-22). New York: Guilford.
18. Ford, J. D., & Courtois, C. A. (2009). Defining and understanding complex trauma and complex traumatic stress disorders. In C. A. Courtois & J. D. Ford (Eds.), Treating complex traumatic stress disorders: An evidence-based guide (pp. 13-30). New York: Guilford.
19. Freud, S. (1920). Beyond the pleasure principle. In J. Strachey (Ed.), The standard edition of the complete psychological works of Sigmund Freud: Vol. XVIII (1920-1922) (pp. 3-64). London: The Hogart Press and the Institute of Psychoanalysis.
20. Freyd, J. J. (1994). Betrayal trauma: Traumatic amnesia as an adaptive response to childhood abuse. Ethics and Behavior, 4(4), 307-329.
21. Friedman, M. J., Davidson, J. R. T., & Stein, D. J. (2009). Psychopharmacotherapy for adults. In E. B. Foa, T. M. Keane, M. J. Friedman, & J. A. Cohen (Eds.), Effective treatments for PTSD: Practice guidelines from the International Society for Traumatic Stress Studies (pp. 245-268). New York: Guilford.
22. Frueh, B. C., Elhai, J. D., & Kaloupek, D. G. (2004). Unresolved problems in the assessment of trauma exposure and posttraumatic reactions. In G. M. Rosen (Ed.), Posttrauamtic stress disorder: Issues and controversies (pp. 63-84). Chichester, England: Wiley.
23. Graeff, F. G., Guimaraes, F. S., De Andrade, T. G., & Deakin, J. F. (1996). Role of 5- HT in stress, anxiety and depression. Pharmacology and Biochemical Behavior, 54(1), 129-141.
24. Grossman, R. (2002). Psychopharmacologic treatment of patients with borderline personality disorder. Psychiatric Annals, 32(6), 357-370.
25. Gunderson, J. G., Daversa, M. T., Grilo, C. M., McGlashan, T. H., Zanarini, M. C., Shea, M. T., et al. (2006). Predictors of 2-year outcome for patients with borderline personality disorder. The American Journal of Psychiatry, 163, 822-826.
26. Gunderson, J. G., & Sabo, A. N. (1993). The phenomenological and conceptual interface between borderline personality disorder and PTSD. American Journal of Psychiatry, 150(1), 19-27.
27. Hamer, D. H., Greenberg, B. D., Sabol, S. Z., & Murphy, D. L. (1999). Role of the serotonin transporter gene in temperament and character. Journal of Personality Disorders, 13(4), 312-328.
28. Herbert, J. D., & Sageman, M. (2004). "First DO NO harm": Emerging guidelines for the treatment of posttraumatic reactions. In G. M. Rosen, (Ed.), Posttraumatic stress disorder: Issues and controversies (pp. 213-232). Chichester, England: Wiley.
29. Herman, J. L. (1997). Trauma and recovery: The aftermath of violence-from domestic abuse to political terror. New York: Basic Books.
30. Horowitz, M. J. (2001). Stress response syndromes: Personality styles and interventions (4th ed.). Northvale, NJ: Aronson.
31. Institute of Medicine. (2008). Treatment of posttraumatic stress disorder: An assessment of the evidence. Washington, DC: National Academies Press.
32. International Society for the Study of Trauma and Dissociation. (2011). Guidelines for treating dissociative identity disorder in adults, 3rd revision. Journal of Trauma & Dissociation, 12, 115-187.
33. Ipser, J., Seedat, S., & Stein, D. J. (2006). Pharmacotherapy for post-traumatic stress disorder-A systematic review and meta-analysis. South African Medical Journal, 96(10), 1088-1096.
34. Jackson, C., Nissenson, K., & Cloitre, M. (2009). Cognitive-behavioral therapy. In C. A. Courtois & J. D. Ford (Eds.), Treating complex traumatic stress disorders: An evidence-based guide (pp. 243-263). New York: Guilford.
35. Janoff-Bulman, R. (1992). Shattered assumptions: Towards a new psychology of trauma. New York: The Free Press.
36. Keane, T. M., Marx, B. P., & Sloan, D. M. (2009). Post-traumatic stress disorder: Definition, prevalence, and risk factors. In P. J. Shiromani, T. M. Keane, & J. E. LeDoux (Eds.), Post-traumatic stress disorder: Basic science and clinical practice (pp. 1-19). New York: Humana.
37. Kehrer, C. A., & Linehan, M. M. (1996). Interpersonal and emotional problem-solving skills and parasuicide among women with borderline personality disorder. Journal of Personality Disorders, 10, 153-163.
38. Knowlton, L. (1999). Marsha Linehan: Dialectic behavior therapy. Psychiatric Times, 16(7). Retrieved from http://www.psychiatrictimes.com/ display/article/10168/ 49651?pageNumber=3
39. Kudler, H. S., Krupnick, J. L., Blank, A. S., Jr., Herman, J. L., & Horowitz, M. J. (2009). Psychodynamic therapy for adults. In E. B. Foa, T. M. Keane, M. J. Friedman, & J. A. Cohen (Eds.), Effective treatments for PTSD: Practice guidelines from the International Society for Traumatic Stress Studies (pp. 346-369). New York: Guilford.
40. Laddis, A. (2008a, November). Lessons from the natural course of chronic posttraumatic disorders. Paper presented at the 25th annual conference of the International Society for the Study of Trauma and Dissociation, Chicago, IL.
41. Laddis, A. (2008b). Regressive social learning results in chronic posttraumatic disorder. ISSTD News, 26(4). Retrieved from E-mail: isstdheadquarters@isst-d.org
42. Laddis, A. (2010). Outcome of crisis intervention for borderline personality disorder and posttraumatic stress disorder: A model for modification of the mechanism of disorder in complex post traumatic syndromes. Annals of General Psychiatry, 9, 19.
43. Leander, N. P., Moore, S. G., & Chartland, T. L. (2009). Mystery moods: Their origins and consequences. In G. B. Moskowitz & H. Grant (Eds.), The psychology of goals (pp. 480-504). New York: Guilford.
44. Levy, K. N. (2008). Psychotherapies and lasting change. American Journal of Psychiatry, 165(5), 556-559.
45. Linehan, M. M. (1997). Special feature: Theory and treatment development and evaluation: Reflections on Benjamin's "models for treatment." Journal of Personality Disorders, 11(4), 325-335.
46. Links, P. S., Boggild, A., & Sarin, N. (2001). Psychopharmacology of personality disorders: Review and emerging issues. Current Psychiatry Reports, 3(1), 70-76.
47. Loewenstein, R. J. (2005). Psychopharmacologic treatments for dissociative identity disorder. Psychiatric Annals, 35(8), 666-673.
48. Luborsky, L., Popp, C., Luborsky, E., & Mark, D. (1994). The core conflictual relationship theme. Psychotherapy Research, 4(3&4), 172-183.
49. Marmar, C. R., Foy, D., Kagan, B., & Pynoos, R. S. (1994). An integrated approach for treating posttraumatic stress. In R. S. Pynoos (Ed.), Posttraumatic stress disorder: A clinical review (pp. 99-132). Lutherville, MD: Sidran Press.
50. McNally, R. J. (2004). Conceptual problems with the DSM-IV criteria for posttraumatic stress disorder. In G. M. Rosen (Ed.), Posttrauamtic stress disorder: Issues and controversies (pp. 1-14). Chichester, England: Wiley.
51. Mercer, D. (2007). Medications in the treatment of borderline personality disorder 2006. Current Psychiatry Reports, 9(1), 53-62.
52. Moran, M. (2006). Interpersonal relationships predict course of BPD. Psychiatric News, 41(13), 24.
53. Nahan, Z., Molnar, C., & George, M. S. (2005). Attachment theory and mentalizationoriented model of borderline personality disorder. In J. M. Oldham, A. E. Skodol, & D. S. Bender (Eds.), The American Psychiatric Publishing textbook of personality disorders (pp. 623-639). Arlington, VA: American Psychiatric Publishing.
54. Oldham, J. M., Bender, D. S., Skodol, A. E., Dyck, I. R., Sanislow, C. A., Yen, S., et al. (2005). Testing an APA practice guideline: Symptom-targeted medication utilization for patients with borderline personality disorder. Focus, 3(3), 484-488.
55. Opler, L. A., Grennan, M. S., & Ford, J. D. (2009). Pharmacotherapy. In C. A. Courtois & J. D. Ford (Eds.), Treating complex traumatic stress disorders: An evidencebased guide (pp. 329-350). New York: Guilford.
56. Paris, J. (2005). Recent advances in the treatment of borderline personality disorder. Canadian Journal of Psychiatry, 50(8), 435-441.
57. Perkonigg, A., Pfister, H., Stein, M. B., Höfler, M., Lieb, R., Maercker, A., et al. (2005). Longitudinal course of posttraumatic stress disorder and posttraumatic stress disorder symptoms in a community sample of adolescents and young adults. American Journal of Psychiatry, 162(7), 1320-1327.
58. Perry, J. C., Banon, E., & Ianni, F. (1999). Effectiveness of psychotherapy for personality disorders. American Journal of Psychiatry, 156(9), 1312-1321.
59. Pukrop, R. (2002). Dimensional personality profiles of borderline personality disorder in comparison with other personality disorders and healthy controls. Journal of Personality Disorders, 16(2), 135-147.
60. Raskind, M. A. (2009). Pharmacologic treatment of PTSD. In P. J. Shiromani, T. M. Keane, & J. E. LeDoux (Eds.), Post-traumatic stress disorder: Basic science and clinical practice (pp. 337-362). New York: Humana.
61. Rosowsky, E., & Gurian, B. (1992). Impact of borderline personality disorder in late life on systems of care. Hospital & Community Psychiatry, 43(4), 386-389.
62. Sansone, R. A., Rytwinski, D., & Gaither, G. A. (2003). Borderline personality and psychotropic medication prescription in an outpatient psychiatry clinic. Comprehensive Psychiatry, 44(6), 454-458.
63. Schatzberg, A. F., Cole, J. O., & DeBattista, C. (2010). Manual of clinical psychopharmacology (7th ed.). Arlington, VA: American Psychiatric Publishing.
64. Schore, A. N. (2003). Affect dysregulation and disorders of the self. New York: Norton.
65. Soloff, P. (1997). Special feature: Psychobiologic perspectives on treatment of personality disorders. Journal of Personality Disorders, 11(4), 336-344.
66. Soloff, P. H. (2005). Pharmacotherapy in borderline personality disorder. In J. G. Gunderson & P. D. Hoffman (Eds.), Understanding and treating borderline personality disorder: A guide for professionals and families (pp. 65-82). Arlington, VA: American Psychiatric Publishing.
67. Stepp, S., & Pilconis, P. A. (2008). Age-related differences in individual DSM criteria for borderline personality disorder. Journal of Personality Disorders, 22(4), 427-432.
68. Stevenson, J., Meares, R., & Comerford, A. (2003). Diminished impulsivity in older patients with borderline personality disorder. American Journal of Psychiatry, 160(1), 165-166.
69. Stone, M. H. (1993). Long-term outcome in personality disorders. British Journal of Psychiatry, 162, 299-313.
70. Tyrer, P., & Bateman, A. W. (2004). Drug treatment for personality disorders. Advances in Psychiatric Treatment, 10, 389-398.
71. van der Kolk, B. A. (2005). Developmental trauma disorder. Psychiatric Annals, 35, 401-408.
72. Zanarini, M. C. (2004). Update on pharmacotherapy of borderline personality disorder. Current Psychiatry Reports, 6(1), 66-70.
73. Zanarini, M. C., Frankenburg, F. R., Reich, D. B., Silk, K. R., Hudson, J. I., & McSweeney, L. B. (2007). The subsyndromal phenomenology of borderline personality disorder: A 10-year follow-up study. American Journal of Psychiatry, 164(6), 929-935.
74. Akiskal, H. S. (2007). The emergence of the bipolar spectrum: Validation along clinical-epidemiologic and familial-genetic lines. Psychopharmacology Bulletin, 40(4), 99-115.
75. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text revision). Washington, DC: Author.
76. American Psychiatric Association. (2001). Practice guideline for the treatment of patients with borderline personality disorder. American Journal of Psychiatry, 158(Suppl. 10), 1-52.
77. American Psychiatric Association. (2004). Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. American Journal of Psychiatry, 161(Suppl. 11), 3-31.
78. Bateman, A. W., & Fonagy, P. (2000). Effectiveness of psychotherapeutic treatment of personality disorder. British Journal of Psychiatry, 177, 138-143.
79. Bateman, A. W., & Tyrer, P. (2004). Psychological treatment for personality disorders. Advances in Psychiatric Treatment, 10, 378-388.
80. Bellino, S., Paradiso, E., & Bogetto, F. (2006). Mood stabilizers and novel antipsychotics in the treatment of borderline personality disorder. Psychiatric Times, 23(8). Retrieved from http://www.psychiatrictimes.com/ display/article/10168/ 46801
81. Benjamin, L. S. (1997). Special feature: Personality disorders: Models for treatment and strategies for treatment development. Journal of Personality Disorders, 11(4), 307-324.
82. Bradley, R., Greene, J., Russ, E., Dutra, L., & Westen, D. (2005). A multidimensional meta-analysis of psychotherapy for PTSD. American Journal of Psychiatry, 162(2), 214-227.
83. Brett, E. A. (1996). The classification of posttraumatic stress disorder. In B. A. van der Kolk, A. C. McFarlane, & L. Weisaeth (Eds.), Traumatic stress: The effects of overwhelming experience on mind, body and society (pp. 117-128). New York: Guilford.
84. Byrne, R. M. J. (2005). The rational imagination: How people create alternatives to reality. Cambridge, MA: The MIT Press.
85. Cahill, S. P., Rothbaum, B. O., Resick, P. A., & Follette, V. M. (2009). Cognitivebehavioral therapy for adults. In E. B. Foa, T. M. Keane, M. J. Friedman, & J. A. Cohen (Eds.), Effective treatments for PTSD: Practice guidelines from the International Society for Traumatic Stress Studies (pp. 139-222). New York: Guilford.
86. Classen, C., Pain, C., Field, N. P., & Woods, P. (2006). Posttraumatic personality disorder: A reformulation of complex posttraumatic stress disorder and borderline personality disorder. Psychiatric Clinics of North America, 29(1), 87-112.
87. Davidson, J. (1994). Issues in the diagnosis of posttraumatic stress disorder. In R. S. Pynoos (Ed.), Posttraumatic stress disorder: A clinical review (pp. 1-15). Lutherville, MD: Sidran Press.
88. Duke, L. M., & Vasterling, J. J. (2005). Epidemiological and methodological issues in neuropsychological research on PTSD. In J. J. Vasterling & C. R. Brewin (Eds.), Neuropsychology of PTSD: Biological, cognitive and clinical perspectives (pp. 3-24). New York: Guilford.
89. Foa, E. B., Keane, T. M., Friedman, M. J., & Cohen, J. A. (Eds.). (2009a). Index: Treatment guidelines. In E. B. Foa, T. M. Keane, M. J. Friedman, & J. A. Cohen (Eds.), Effective treatments for PTSD: Practice guidelines from the International Society for Traumatic Stress Studies (pp. 537-613). New York: Guilford.
90. Foa, E. B., Keane, T. M., Friedman, M. J., & Cohen, J. A. (2009b). Introduction. In E. B. Foa, T. M. Keane, M. J. Friedman, & J. A. Cohen (Eds.), Effective treatments for PTSD: Practice guidelines from the International Society for Traumatic Stress Studies (pp. 1-22). New York: Guilford.
91. Ford, J. D., & Courtois, C. A. (2009). Defining and understanding complex trauma and complex traumatic stress disorders. In C. A. Courtois & J. D. Ford (Eds.), Treating complex traumatic stress disorders: An evidence-based guide (pp. 13-30). New York: Guilford.
92. Freud, S. (1920). Beyond the pleasure principle. In J. Strachey (Ed.), The standard edition of the complete psychological works of Sigmund Freud: Vol. XVIII (1920-1922) (pp. 3-64). London: The Hogart Press and the Institute of Psychoanalysis.
93. Freyd, J. J. (1994). Betrayal trauma: Traumatic amnesia as an adaptive response to childhood abuse. Ethics and Behavior, 4(4), 307-329.
94. Friedman, M. J., Davidson, J. R. T., & Stein, D. J. (2009). Psychopharmacotherapy for adults. In E. B. Foa, T. M. Keane, M. J. Friedman, & J. A. Cohen (Eds.), Effective treatments for PTSD: Practice guidelines from the International Society for Traumatic Stress Studies (pp. 245-268). New York: Guilford.
95. Frueh, B. C., Elhai, J. D., & Kaloupek, D. G. (2004). Unresolved problems in the assessment of trauma exposure and posttraumatic reactions. In G. M. Rosen (Ed.), Posttrauamtic stress disorder: Issues and controversies (pp. 63-84). Chichester, England: Wiley.
96. Graeff, F. G., Guimaraes, F. S., De Andrade, T. G., & Deakin, J. F. (1996). Role of 5- HT in stress, anxiety and depression. Pharmacology and Biochemical Behavior, 54(1), 129-141.
97. Grossman, R. (2002). Psychopharmacologic treatment of patients with borderline personality disorder. Psychiatric Annals, 32(6), 357-370.
98. Gunderson, J. G., Daversa, M. T., Grilo, C. M., McGlashan, T. H., Zanarini, M. C., Shea, M. T., et al. (2006). Predictors of 2-year outcome for patients with borderline personality disorder. The American Journal of Psychiatry, 163, 822-826.
99. Gunderson, J. G., & Sabo, A. N. (1993). The phenomenological and conceptual interface between borderline personality disorder and PTSD. American Journal of Psychiatry, 150(1), 19-27.
100. Hamer, D. H., Greenberg, B. D., Sabol, S. Z., & Murphy, D. L. (1999). Role of the serotonin transporter gene in temperament and character. Journal of Personality Disorders, 13(4), 312-328.
101. Herbert, J. D., & Sageman, M. (2004). "First DO NO harm": Emerging guidelines for the treatment of posttraumatic reactions. In G. M. Rosen, (Ed.), Posttraumatic stress disorder: Issues and controversies (pp. 213-232). Chichester, England: Wiley.
102. Herman, J. L. (1997). Trauma and recovery: The aftermath of violence-from domestic abuse to political terror. New York: Basic Books.
103. Horowitz, M. J. (2001). Stress response syndromes: Personality styles and interventions (4th ed.). Northvale, NJ: Aronson.
104. Institute of Medicine. (2008). Treatment of posttraumatic stress disorder: An assessment of the evidence. Washington, DC: National Academies Press.
105. International Society for the Study of Trauma and Dissociation. (2011). Guidelines for treating dissociative identity disorder in adults, 3rd revision. Journal of Trauma & Dissociation, 12, 115-187.
106. Ipser, J., Seedat, S., & Stein, D. J. (2006). Pharmacotherapy for post-traumatic stress disorder-A systematic review and meta-analysis. South African Medical Journal, 96(10), 1088-1096.
107. Jackson, C., Nissenson, K., & Cloitre, M. (2009). Cognitive-behavioral therapy. In C. A. Courtois & J. D. Ford (Eds.), Treating complex traumatic stress disorders: An evidence-based guide (pp. 243-263). New York: Guilford.
108. Janoff-Bulman, R. (1992). Shattered assumptions: Towards a new psychology of trauma. New York: The Free Press.
109. Keane, T. M., Marx, B. P., & Sloan, D. M. (2009). Post-traumatic stress disorder: Definition, prevalence, and risk factors. In P. J. Shiromani, T. M. Keane, & J. E. LeDoux (Eds.), Post-traumatic stress disorder: Basic science and clinical practice (pp. 1-19). New York: Humana.
110. Kehrer, C. A., & Linehan, M. M. (1996). Interpersonal and emotional problem-solving skills and parasuicide among women with borderline personality disorder. Journal of Personality Disorders, 10, 153-163.
111. Knowlton, L. (1999). Marsha Linehan: Dialectic behavior therapy. Psychiatric Times, 16(7). Retrieved from http://www.psychiatrictimes.com/ display/article/10168/ 49651?pageNumber=3
112. Kudler, H. S., Krupnick, J. L., Blank, A. S., Jr., Herman, J. L., & Horowitz, M. J. (2009). Psychodynamic therapy for adults. In E. B. Foa, T. M. Keane, M. J. Friedman, & J. A. Cohen (Eds.), Effective treatments for PTSD: Practice guidelines from the International Society for Traumatic Stress Studies (pp. 346-369). New York: Guilford.
113. Laddis, A. (2008a, November). Lessons from the natural course of chronic posttraumatic disorders. Paper presented at the 25th annual conference of the International Society for the Study of Trauma and Dissociation, Chicago, IL.
114. Laddis, A. (2008b). Regressive social learning results in chronic posttraumatic disorder. ISSTD News, 26(4). Retrieved from E-mail: isstdheadquarters@isst-d.org
115. Laddis, A. (2010). Outcome of crisis intervention for borderline personality disorder and posttraumatic stress disorder: A model for modification of the mechanism of disorder in complex post traumatic syndromes. Annals of General Psychiatry, 9, 19.
116. Leander, N. P., Moore, S. G., & Chartland, T. L. (2009). Mystery moods: Their origins and consequences. In G. B. Moskowitz & H. Grant (Eds.), The psychology of goals (pp. 480-504). New York: Guilford.
117. Levy, K. N. (2008). Psychotherapies and lasting change. American Journal of Psychiatry, 165(5), 556-559.
118. Linehan, M. M. (1997). Special feature: Theory and treatment development and evaluation: Reflections on Benjamin's "models for treatment." Journal of Personality Disorders, 11(4), 325-335.
119. Links, P. S., Boggild, A., & Sarin, N. (2001). Psychopharmacology of personality disorders: Review and emerging issues. Current Psychiatry Reports, 3(1), 70-76.
120. Loewenstein, R. J. (2005). Psychopharmacologic treatments for dissociative identity disorder. Psychiatric Annals, 35(8), 666-673.
121. Luborsky, L., Popp, C., Luborsky, E., & Mark, D. (1994). The core conflictual relationship theme. Psychotherapy Research, 4(3&4), 172-183.
122. Marmar, C. R., Foy, D., Kagan, B., & Pynoos, R. S. (1994). An integrated approach for treating posttraumatic stress. In R. S. Pynoos (Ed.), Posttraumatic stress disorder: A clinical review (pp. 99-132). Lutherville, MD: Sidran Press.
123. McNally, R. J. (2004). Conceptual problems with the DSM-IV criteria for posttraumatic stress disorder. In G. M. Rosen (Ed.), Posttrauamtic stress disorder: Issues and controversies (pp. 1-14). Chichester, England: Wiley.
124. Mercer, D. (2007). Medications in the treatment of borderline personality disorder 2006. Current Psychiatry Reports, 9(1), 53-62.
125. Moran, M. (2006). Interpersonal relationships predict course of BPD. Psychiatric News, 41(13), 24.
126. Nahan, Z., Molnar, C., & George, M. S. (2005). Attachment theory and mentalizationoriented model of borderline personality disorder. In J. M. Oldham, A. E. Skodol, & D. S. Bender (Eds.), The American Psychiatric Publishing textbook of personality disorders (pp. 623-639). Arlington, VA: American Psychiatric Publishing.
127. Oldham, J. M., Bender, D. S., Skodol, A. E., Dyck, I. R., Sanislow, C. A., Yen, S., et al. (2005). Testing an APA practice guideline: Symptom-targeted medication utilization for patients with borderline personality disorder. Focus, 3(3), 484-488.
128. Opler, L. A., Grennan, M. S., & Ford, J. D. (2009). Pharmacotherapy. In C. A. Courtois & J. D. Ford (Eds.), Treating complex traumatic stress disorders: An evidencebased guide (pp. 329-350). New York: Guilford.
129. Paris, J. (2005). Recent advances in the treatment of borderline personality disorder. Canadian Journal of Psychiatry, 50(8), 435-441.
130. Perkonigg, A., Pfister, H., Stein, M. B., Höfler, M., Lieb, R., Maercker, A., et al. (2005). Longitudinal course of posttraumatic stress disorder and posttraumatic stress disorder symptoms in a community sample of adolescents and young adults. American Journal of Psychiatry, 162(7), 1320-1327.
131. Perry, J. C., Banon, E., & Ianni, F. (1999). Effectiveness of psychotherapy for personality disorders. American Journal of Psychiatry, 156(9), 1312-1321.
132. Pukrop, R. (2002). Dimensional personality profiles of borderline personality disorder in comparison with other personality disorders and healthy controls. Journal of Personality Disorders, 16(2), 135-147.
133. Raskind, M. A. (2009). Pharmacologic treatment of PTSD. In P. J. Shiromani, T. M. Keane, & J. E. LeDoux (Eds.), Post-traumatic stress disorder: Basic science and clinical practice (pp. 337-362). New York: Humana.
134. Rosowsky, E., & Gurian, B. (1992). Impact of borderline personality disorder in late life on systems of care. Hospital & Community Psychiatry, 43(4), 386-389.
135. Sansone, R. A., Rytwinski, D., & Gaither, G. A. (2003). Borderline personality and psychotropic medication prescription in an outpatient psychiatry clinic. Comprehensive Psychiatry, 44(6), 454-458.
136. Schatzberg, A. F., Cole, J. O., & DeBattista, C. (2010). Manual of clinical psychopharmacology (7th ed.). Arlington, VA: American Psychiatric Publishing.
137. Schore, A. N. (2003). Affect dysregulation and disorders of the self. New York: Norton.
138. Soloff, P. (1997). Special feature: Psychobiologic perspectives on treatment of personality disorders. Journal of Personality Disorders, 11(4), 336-344.
139. Soloff, P. H. (2005). Pharmacotherapy in borderline personality disorder. In J. G. Gunderson & P. D. Hoffman (Eds.), Understanding and treating borderline personality disorder: A guide for professionals and families (pp. 65-82). Arlington, VA: American Psychiatric Publishing.
140. Stepp, S., & Pilconis, P. A. (2008). Age-related differences in individual DSM criteria for borderline personality disorder. Journal of Personality Disorders, 22(4), 427-432.
141. Stevenson, J., Meares, R., & Comerford, A. (2003). Diminished impulsivity in older patients with borderline personality disorder. American Journal of Psychiatry, 160(1), 165-166.
142. Stone, M. H. (1993). Long-term outcome in personality disorders. British Journal of Psychiatry, 162, 299-313.
143. Tyrer, P., & Bateman, A. W. (2004). Drug treatment for personality disorders. Advances in Psychiatric Treatment, 10, 389-398.
144. van der Kolk, B. A. (2005). Developmental trauma disorder. Psychiatric Annals, 35, 401-408.
145. Zanarini, M. C. (2004). Update on pharmacotherapy of borderline personality disorder. Current Psychiatry Reports, 6(1), 66-70.
146. Zanarini, M. C., Frankenburg, F. R., Reich, D. B., Silk, K. R., Hudson, J. I., & McSweeney, L. B. (2007). The subsyndromal phenomenology of borderline personality disorder: A 10-year follow-up study. American Journal of Psychiatry, 164(6), 929-935.